ELMO1 variants and susceptibility to diabetic nephropathy in American Indians

Molecular Genetics and Metabolism

Volumn 101, Issue 4, 2010, Pages 383-390

  Hanson, Robert L ^a   Millis, Meredith P ^b   Young, Naomi J ^b   Kobes, Sayuko ^a   Nelson, Robert G ^a   Knowler, William C ^a   DiStefano, Johanna K ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Association analysis; Candidate gene study; End stage renal disease; Genetic susceptibility; Pima Indians

Indexed keywords

ADULT; AMERICAN INDIAN; ARTICLE; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

PIMA;

EID: 78649325894     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2010.08.014     Document Type: Article

References (27)

1. Nelson R.G., Kunzelman C.L., Pettitt D.J., Saad M.F., Bennett P.H., Knowler W.C. Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 1989, 32:870-876.
2. Pugh J.A., Medina R., Ramirez M. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 1993, 36:1094-1098.
3. Gall M.A., Rossing P., Skott P., Damsbo P., Vaag A., Bech K., Dejgaard A., Lauritzen M., Lauritzen E., Hougaard P., et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991, 34:655-661.
4. Nelson R.G., Knowler W.C., Pettitt D.J., Hanson R.L., Bennett P.H. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diab. Care 1995, 18:182-187.
5. Ravid M., Brosh D., Ravid-Safran D., Levy Z., Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch. Intern. Med. 1998, 158:998-1004.
6. Pettitt D.J., Saad M.F., Bennett P.H., Nelson R.G., Knowler W.C. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990, 33:438-443.
7. Quinn M., Angelico M.C., Warram J.H., Krolewski A.S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996, 39:940-945.
8. Seaquist E.R., Goetz F.C., Rich S., Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N. Engl J. Med. 1989, 320:1161-1165.
9. Shimazaki A., Kawamura Y., Kanazawa A., Sekine A., Saito S., Tsunoda T., Koya D., Babazono T., Tanaka Y., Matsuda M., Kawai K., Iiizumi T., Imanishi M., Shinosaki T., Yanagimoto T., Ikeda M., Omachi S., Kashiwagi A., Kaku K., Iwamoto Y., Kawamori R., Kikkawa R., Nakajima M., Nakamura Y., Maeda S. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 2005, 54:1171-1178.
10. Leak T.S., Perlegas P.S., Smith S.G., Keene K.L., Hicks P.J., Langefeld C.D., Mychaleckyj J.C., Rich S.S., Kirk J.K., Freedman B.I., Bowden D.W., Sale M.M. Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann. Hum. Genet. 2009, 73:152-159.
11. Craig D.W., Millis M.P., DiStefano J.K. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes. Diabet. Med. 2009, 26:1090-1098.
12. Pezzolesi M.G., Katavetin P., Kure M., Poznik G.D., Skupien J., Mychaleckyj J.C., Rich S.S., Warram J.H., Krolewski A.S. Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes 2009, 58:2698-2702.
13. Imperatore G., Knowler W.C., Nelson R.G., Hanson R.L. Genetics of diabetic nephropathy in the Pima Indians. Curr. Diab. Rep. 2001, 1:275-281.
14. Nelson R.G., Newman J.M., Knowler W.C., Sievers M.L., Kunzelman C.L., Pettitt D.J., Moffett C.D., Teutsch S.M., Bennett P.H. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988, 31:730-736.
15. Knowler W.C., Bennett P.H., Hamman R.F., Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am. J. Epidemiol. 1978, 108:497-505.
16. Wolford J.K., Yeatts K.A., Red Eagle A.R., Nelson R.G., Knowler W.C., Hanson R.L. Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians. Diabet. Med. 2006, 23:367-376.
17. Imperatore G., Knowler W.C., Pettitt D.J., Kobes S., Bennett P.H., Hanson R.L. Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 2000, 49:1049-1056.
18. Hanson R.L., Looker H.C., Ma L., Muller Y.L., Baier L.J., Knowler W.C. Design and analysis of genetic association studies to finely map a locus identified by linkage analysis: sample size and power calculations. Ann. Hum. Genet. 2006, 70:332-349.
19. Stouffer S.A., Suchman E.A., DaVinney L.C., Star S.A., Williams R.M. How the volumes were produced. Adjustment to Army Life 1949, vol. i:45. Princeton University Press, Princeton, NJ.
20. Vozarova de Courten B., Hanson R.L., Funahashi T., Lindsay R.S., Matsuzawa Y., Tanaka S., Thameem F., Gruber J.D., Froguel P., Wolford J.K. Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 2005, 54:284-289.
21. [21] S. Kim, H.E. Abboud, M.V. Pahl, J. Tayek, S. Snyder, J. Tamkin, H. Alcorn, Jr., E. Ipp, C.C. Nast, R.C. Elston, S.K. Iyengar, S.G. Adler, Examination of Association with Candidate Genes for Diabetic Nephropathy in a Mexican American Population. Clin J Am Soc Nephrol. 5 (2010) 1072-1078.
22. Brown M. A method for combining non-independent one-sided tests of significance. Biometrics 1975, 31:987-992.
23. Elston R.C. On Fisher's method of combining p-values. Biom. J 1991, 3:339-345.
24. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. Am. J. Hum. Genet. 2007, 80:531-538.
25. Placha G., Canani L.H., Warram J.H., Krolewski A.S. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv. Chron. Kidney Dis. 2005, 12:155-169.
26. Duggal P., Gillanders E.M., Holmes T.N., Bailey-Wilson J.E. Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies. BMC Genomics 2008, 9:516.
27. Ke X., Hunt S., Tapper W., Lawrence R., Stavrides G., Ghori J., Whittaker P., Collins A., Morris A.P., Bentley D., Cardon L.R., Deloukas P. The impact of SNP density on fine-scale patterns of linkage disequilibrium. Hum. Mol. Genet. 2004, 13:577-588.